Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 ...

As we move deeper into this decade, the question “Should we invest in research?” is becoming “How do we weave market ...

Control of PRRSV, PCV2, IAV through vaccination, management and disease elimination most effective way of preventing the ...

Kyle Busch's lawsuit against Pacific Life and his former insurance agent provides a window into potential issues around ...

Rate volatility in advanced economies drove even larger moves in G7-linked derivatives. BIS reports that euro-denominated ...

Learn about crown jewels: a company's most precious assets, how they impact business strategies, and defenses against hostile ...

Detailed price information for Cellectis S.A. ADR (CLLS-Q) from The Globe and Mail including charting and trades.

Palantir Technologies Inc. is rated a Strong Buy, driven by robust commercial and government revenue growth. Learn more about ...

North American supply growth, cost cuts, and NAL expansion driving 2026 profitability inflection. Click here to read more.

The one-year executive education programme is designed to equip mid-career professionals with strategic and practical ...

Announced new data demonstrating a unique mechanism of action supporting the best-in-class potential of rademikibart –– Recruitment ongoing for ...

News from the week beginning 5t January including items from 11:11 Systems, Cybage Software, Deltek, Klient, Monta, Planful, ...